Bevacizumab: In First-Line Treatment of Metastatic Breast Cancer

By Scott Lesley J.  

Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. : 1793-1799

Adis International

Access to resources Recommend Favorite

Bevacizumab: A Review of its Use in Combination with Paclitaxel or Capecitabine as First-Line Therapy for HER2-Negative Metastatic Breast Cancer

By Croom Katherine F.   Dhillon Sohita  

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2213-2229

Adis International

Access to resources Recommend Favorite

Drug Interaction Potential of Trastuzumab Emtansine (T-DM1) Combined with Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer

By  

Current Drug Metabolism, Vol. 13, Iss. 7, 2012-09 ,pp. : 911-922

Bentham Science Publishers

Access to resources Recommend Favorite

Bevacizumab in First-Line Treatment of Metastatic Breast Cancer: A Viewpoint by David Miles

By Miles David  

Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. : 1800-1801

Adis International

Access to resources Recommend Favorite

First-line therapy with trastuzumab plus paclitaxel and carboplatin may be active in patients with HER-2 over-expressing metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite